Psychiatric Times

Why We Need to Know How Clinicians Use the DSM

We recently interviewed Dr Michael First about his research on the clinical use of the DSM. A chief goal of the discussion? To bring your attention to a survey that seeks to examine and shed light on how the DSM is used.

©CoraMax/Shutterstock

Recent Content

Monthly Roundup: Top 6 Psychiatry Articles in February

Psychiatic Times Editors

March 04, 2015 | Cultural Psychiatry, Couch in Crisis

By Psychiatic Times Editors

Editors' choices of noteworthy psychiatry blogs, CMEs, research studies, cases, and books from around the Web.

The Lasting Effects of Marijuana Use

Herbert D. Kleber, MD

March 03, 2015 | Addiction, AAAP 2014, Substance Use Disorder

By Herbert D. Kleber, MD

There is increasing evidence that individuals who try marijuana during their early teenage years are affected neurologically for a decade or more at least until one's 20s and perhaps even longer. More in this video.

Gender Identity, Bruce Jenner, and Me

H. Steven Moffic, MD

March 02, 2015 | Couch in Crisis, Gender Issues

By H. Steven Moffic, MD

A commentary that is both professional and personal in nature, written by a psychiatrist who has helped hundreds of transitioning patients adapt to their external gender appearance and societal expectations.

Introduction: Neuropsychiatry Is Thriving

Fred Ovsiew, MD

February 27, 2015 | Special Reports, Neuropsychiatry

By Fred Ovsiew, MD

Neuropsychiatry is thriving, and the articles in this Special Report demonstrate its breadth and depth while providing the opportunity to characterize and delimit its scope.

Management of Mild Traumatic Brain Injury

Adam M. Willis, MD, PhD

Jon P. Williams, DO, PhD

John H. Sladky, MD

February 27, 2015 | Special Reports, Neuropsychiatry

By Adam M. Willis, MD, PhD, Jon P. Williams, DO, PhD, John H. Sladky, MD, and Jeffrey C. McClean, MD

A considerable overlap exists between TBI and disorders in cognition, behavior, and personality, which can provide even greater clinical challenges. More than 70% of the cases of TBI are mild, which makes this subgroup of particular clinical interest.

Update on Psychogenic Nonepileptic Seizures

Jason Brandt, PhD

Antonio N. Puente, PhD

February 27, 2015 | Special Reports, Cognitive Behavioral Therapy, Neuropsychiatry, Psychopharmacology, Psychotherapy, Somatoform Disorder

By Jason Brandt, PhD and Antonio N. Puente, PhD

The authors take an in-depth look at the evaluation, diagnosis, and fundamental treatment recommendations, protocols, and guides to therapy for psychogenic nonepileptic seizures.

Transcranial Magnetic Stimulation in Neuropsychiatry: An Update

Jonathan Hsu, BHSc

Daniel M. Blumberger, MD, MSc, FRCPC

February 27, 2015 | Special Reports, Alzheimer, Geriatric Psychiatry, Neuropsychiatry, Psychopharmacology, Transcranial Magnetic Stimulation

By Jonathan Hsu, BHSc and Daniel M. Blumberger, MD, MSc, FRCPC

The potential of TMS as a treatment for cognitive disorders, fatigue, pain, and other manifestations of brain disease is discussed, as is the encouraging prospect for neuropsychiatric management of many patients.

Videos
Slideshows

The Lasting Effects of Marijuana Use
Herbert D. Kleber, MD
March 03, 2015 | Addiction, AAAP 2014, Substance Use Disorder
By Herbert D. Kleber, MD
There is increasing evidence that individuals who try marijuana during their early teenage years are affected neurologically for a decade or more at least until one's 20s and perhaps even longer. More in this video.
Seeing the Forest Through the Fees: Earning Your Green Using the New, Confusing CPT Codes
Vikram Shah, MD, MBA
Stuart Lustig, MD, MPH
January 15, 2015 | Psychiatry Compensation, Career
By Vikram Shah, MD, MBA and Stuart Lustig, MD, MPH
E&M codes are more complicated to learn, but psychiatrists can now deservedly get paid more for treating their more complicated patients or for engaging in time-consuming activities. Here: a focus on codes 99212 to 99215.
Substance Abuse by “Mature” Adults
Louis A. Trevisan, MD
January 15, 2015 | Substance Use Disorder, AAAP 2014
By Louis A. Trevisan, MD
Is your older patient using or abusing drugs or alcohol? This video reviews how general psychiatrists can provide effective intervention when a substance abuse problem is identified.
Should Recreational Use of Marijuana Be Legalized?
Kevin P. Hill, MD, MHS
January 08, 2015 | Addiction, AAAP 2014
By Kevin P. Hill, MD, MHS
A brief video on the pros and cons of legalizing the recreational use of marijuana.

Monthly Roundup: Top 6 Psychiatry Articles in February
Psychiatic Times Editors
March 04, 2015 | Cultural Psychiatry, Couch in Crisis
By Psychiatic Times Editors
Editors' choices of noteworthy psychiatry blogs, CMEs, research studies, cases, and books from around the Web.
5 Things to Know About Eating Disorders
Psychiatric Times Editors
February 25, 2015 | Eating Disorders, Child Adolescent Psychiatry
By Psychiatric Times Editors
Eating disorders are often complicated by devastating medical problems and may result in death. Although studies suggest a multifactorial cause for the disorder, treatment is a still challenge.
10 Facts About Geriatric Pharmacotherapy
Sandra Jacobson, MD
February 03, 2015 | Geriatric Psychiatry, Psychopharmacology, Tipsheets
By Sandra Jacobson, MD
It is important to monitor and alter psychotropic medications and dosages in older patients as needed. This slideshow serves as quick reference on the effects of pharmacokinetic and pharmacodynamic changes in the elderly.
8 Reasons a Psychotropic Medication May Be Discontinued
John J. Miller, MD
January 28, 2015 | Psychopharmacology, Bipolar Disorder, Challenging Cases, Major Depressive Disorder, Mood Disorders, Schizophrenia, Tipsheets
By John J. Miller, MD
The psychiatrist’s role is to act as a consultant to maximize the likelihood of a successful taper and discontinuation and to minimize collateral morbidities or withdrawal complications. This slideshow features common scenarios in which a planned discontinuation of psychotropic medications occurs.